Comparative effectiveness of SGLT2 inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases
adults report having taken a GLP-1 agonist medication
Why I Am Requesting an Exception: Obesity Is a Chronic Disease With Serious Health Consequences Obesity is widely recognized by the medical community as a chronic, progressive disease associated with increased risk of cardiovascular disease, type 2 diabetes, stroke, certain cancers, sleep apnea, and other serious conditions
What Causes Hair Shedding While on a GLP-1
Can J Diabetes 2020;44:575-91
1) Moreover, several large, prospective, randomized studies have been developed to investigate the association between GLP-1 RAs intake in DM 2 patients and a known cardiovascular disease (CVD) or high cardiovascular (CV) risk